Parallel Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Parallel Advisors’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$16.1K	Buy
2025 Q1	$14.9K	Buy
2024 Q4	$872	Buy
2024 Q3	$787	Buy
2023 Q2	–	Hold
2023 Q1	–	Sell
2022 Q4	$2.58K	Buy
2022 Q3	$0	Buy
2021 Q4	–	Sell
2021 Q3	$0	Sell
2021 Q2	$1K	Buy